ClinicalTrials.Veeva

Menu

Predicting Factors for Mortality in Congenital Heart Disease Patients After Shunt Procedure in Developing Country.

U

Universitas Sumatera Utara

Status

Completed

Conditions

Cyanotic Congenital Heart Disease

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Blalock Taussig (BT) is a palliative procedure that preserves blood circulation to the lungs and alleviates cyanosis in patients with congenital heart diseases and reduced pulmonary blood flow. BT shunt remains a routinely performed procedure in developing countries before definitive surgery. However, evidence on predictors factors of mortality after this procedure is still scarce in Indonesia.

Enrollment

197 patients

Sex

All

Ages

1 day to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All CHD pediatric patients with a previous history of BT shunt procedure.

Exclusion criteria

  • Pediatric patients with incomplete medical records

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems